Canaccord Genuity initiated coverage on Nature's Sunshine with a new price target
$NATR
Biotechnology: Pharmaceutical Preparations
Health Care
Canaccord Genuity initiated coverage of Nature's Sunshine with a rating of Buy and set a new price target of $18.00